Skip to main content
US EQUITIES AFTER-HOURS CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
BI

BIBETF / FundProShares Ultra Nasdaq Biotechnology

$108.38 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment BIB's does — no target price to set, unlike a price alert.

Sharia status
NOT COMPLIANT
Screened by look-through to its filed holdings — 48% of portfolio weight covered
Fund look-through

ProShares Ultra Nasdaq Biotechnology ETF · ProShares Trust

264 holdings · as of 2026-08-31 (2.6 months ago)

NON-COMPLIANT At least 14.50% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 50% turns out to be. Matching more holdings can only raise this share, never lower it.

264 holdings, 196 matched (48% of weight). Portfolio as of 2026-08-31, filed 2026-10-28. Source: SEC Form N-PORT.

5.61% of this portfolio’s income is non-permissible — weighted across holdings, computed over 43% of portfolio weight (146 of 264 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.

Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.

All holdings (264) · showing 1–250
HoldingStatusWeightEvery methodology, and the debt ratio behind it
Repurchase Agreement UNSCREENED 9.22% no in-house ratios for this holding
Repurchase Agreement UNSCREENED 6.13% no in-house ratios for this holding
N/A UNSCREENED 5.57% no in-house ratios for this holding
N/A UNSCREENED 5.21% no in-house ratios for this holding
ProShares GENIUS Money Market ETF UNSCREENED 4.94% no in-house ratios for this holding
AMGN Amgen, Inc. COMPLIANT 4.72% AAOIFI21.4% Usmani56.2% Dow Jones Islamic31.0% S&P Shariah32.5% MSCI Islamic56.2% MSCI Islamic M-Series32.5% FTSE Shariah56.2%
VRTX Vertex Pharmaceuticals, Inc. COMPLIANT 4.50% AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0%
GILD Gilead Sciences, Inc. COMPLIANT 4.02% AAOIFI12.6% Usmani51.0% Dow Jones Islamic17.6% S&P Shariah20.4% MSCI Islamic51.0% MSCI Islamic M-Series20.4% FTSE Shariah51.0%
Repurchase Agreement UNSCREENED 3.68% no in-house ratios for this holding
REGN Regeneron Pharmaceuticals, Inc. COMPLIANT 2.90% AAOIFI2.0% Usmani6.1% Dow Jones Islamic3.1% S&P Shariah2.7% MSCI Islamic4.5% MSCI Islamic M-Series2.7% FTSE Shariah4.5%
MRNA Moderna, Inc. NON_COMPLIANT 1.96% AAOIFI1.5% Usmani9.4% Dow Jones Islamic5.4% S&P Shariah4.5% MSCI Islamic9.2% MSCI Islamic M-Series4.5% FTSE Shariah4.4%
Repurchase Agreement UNSCREENED 1.96% no in-house ratios for this holding
RVMDW Revolution Medicines, Inc. NON_COMPLIANT 1.54% AAOIFI49.8% Usmani14.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic14.9% MSCI Islamic M-Series— FTSE Shariah11.3%
Repurchase Agreement UNSCREENED 1.23% no in-house ratios for this holding
ILMN Illumina, Inc. COMPLIANT 1.14% AAOIFI1.8% Usmani7.7% Dow Jones Islamic2.5% S&P Shariah2.5% MSCI Islamic7.7% MSCI Islamic M-Series2.5% FTSE Shariah0.0%
ALNY Alnylam Pharmaceuticals, Inc. COMPLIANT 1.13% AAOIFI1.1% Usmani3.1% Dow Jones Islamic0.6% S&P Shariah0.7% MSCI Islamic3.1% MSCI Islamic M-Series0.7% FTSE Shariah0.0%
BIIB Biogen, Inc. COMPLIANT 1.13% AAOIFI19.7% Usmani23.1% Dow Jones Islamic29.8% S&P Shariah27.2% MSCI Islamic23.1% MSCI Islamic M-Series27.2% FTSE Shariah22.7%
N/A UNSCREENED 1.05% no in-house ratios for this holding
ARGX Argenx SE COMPLIANT 1.01% AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah—
RPRX Royalty Pharma plc NON_COMPLIANT 0.96% AAOIFI21.8% Usmani44.1% Dow Jones Islamic53.0% S&P Shariah60.4% MSCI Islamic44.1% MSCI Islamic M-Series60.4% FTSE Shariah44.1%
N/A UNSCREENED 0.95% no in-house ratios for this holding
Insmed, Inc. UNSCREENED 0.93% no in-house ratios for this holding
Roivant Sciences Ltd. UNSCREENED 0.88% no in-house ratios for this holding
INCY Incyte Corp. COMPLIANT 0.87% AAOIFI0.0% Usmani0.5% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
UTHR United Therapeutics Corp. NON_COMPLIANT 0.76% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
GH Guardant Health, Inc. COMPLIANT 0.74% AAOIFI8.7% Usmani89.7% Dow Jones Islamic14.8% S&P Shariah19.6% MSCI Islamic89.7% MSCI Islamic M-Series19.6% FTSE Shariah79.7%
VTRS Viatris, Inc. NON_COMPLIANT 0.68% AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1%
N/A UNSCREENED 0.67% no in-house ratios for this holding
MEDP Medpace Holdings, Inc. COMPLIANT 0.60% AAOIFIpass Usmani— Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
ASND Ascendis Pharma A/S COMPLIANT 0.57% AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah—
JAZZ Jazz Pharmaceuticals plc NON_COMPLIANT 0.55% AAOIFI36.6% Usmani46.9% Dow Jones Islamic54.5% S&P Shariah60.7% MSCI Islamic46.9% MSCI Islamic M-Series60.7% FTSE Shariah46.4%
NBIX Neurocrine Biosciences, Inc. COMPLIANT 0.55% AAOIFI2.7% Usmani8.0% Dow Jones Islamic3.3% S&P Shariah3.3% MSCI Islamic8.0% MSCI Islamic M-Series3.3% FTSE Shariah0.0%
INVESCO GOVT AND AGCY LEX UNSCREENED 0.54% no in-house ratios for this holding
BBIO Bridgebio Pharma, Inc. COMPLIANT 0.53% AAOIFI17.4% Usmani122.4% Dow Jones Islamic24.2% S&P Shariah29.2% MSCI Islamic122.4% MSCI Islamic M-Series29.2% FTSE Shariah121.7%
EXEL Exelixis, Inc. COMPLIANT 0.48% AAOIFI1.0% Usmani6.5% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic6.5% MSCI Islamic M-Series1.6% FTSE Shariah0.0%
HALO Halozyme Therapeutics, Inc. COMPLIANT 0.45% AAOIFI29.5% Usmani93.6% Dow Jones Islamic38.6% S&P Shariah42.8% MSCI Islamic93.6% MSCI Islamic M-Series42.8% FTSE Shariah93.6%
BMRN BioMarin Pharmaceutical, Inc. NON_COMPLIANT 0.44% AAOIFI37.0% Usmani36.1% Dow Jones Islamic36.6% S&P Shariah32.3% MSCI Islamic36.1% MSCI Islamic M-Series32.3% FTSE Shariah36.1%
MDGL Madrigal Pharmaceuticals, Inc. COMPLIANT 0.44% AAOIFI3.6% Usmani24.7% Dow Jones Islamic3.7% S&P Shariah4.4% MSCI Islamic24.7% MSCI Islamic M-Series4.4% FTSE Shariah23.8%
ONC BeOne Medicines Ltd. COMPLIANT 0.42% AAOIFI2.8% Usmani12.5% Dow Jones Islamic0.3% S&P Shariah0.3% MSCI Islamic12.5% MSCI Islamic M-Series0.3% FTSE Shariah11.7%
22UA.DE BioNTech SE NON_COMPLIANT 0.42% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
N/A UNSCREENED 0.41% no in-house ratios for this holding
ARWR Arrowhead Pharmaceuticals, Inc. COMPLIANT 0.41% AAOIFI11.9% Usmani46.3% Dow Jones Islamic12.9% S&P Shariah15.5% MSCI Islamic46.3% MSCI Islamic M-Series15.5% FTSE Shariah39.3%
TEM Tempus AI, Inc. COMPLIANT 0.39% AAOIFI0.7% Usmani3.5% Dow Jones Islamic0.8% S&P Shariahpass MSCI Islamic3.5% MSCI Islamic M-Seriespass FTSE Shariah0.0%
KRYS Krystal Biotech, Inc. NON_COMPLIANT 0.37% AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
Summit Therapeutics, Inc. UNSCREENED 0.37% no in-house ratios for this holding
SNY Sanofi SA COMPLIANT 0.36% AAOIFI20.8% Usmani14.7% Dow Jones Islamic38.1% S&P Shariah38.6% MSCI Islamic14.7% MSCI Islamic M-Series38.6% FTSE Shariah14.7%
AXSM Axsome Therapeutics, Inc. COMPLIANT 0.36% AAOIFI2.9% Usmani27.1% Dow Jones Islamic2.8% S&P Shariah3.3% MSCI Islamic25.3% MSCI Islamic M-Series3.3% FTSE Shariah22.7%
IONS Ionis Pharmaceuticals, Inc. NON_COMPLIANT 0.35% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
Praxis Precision Medicines, Inc. UNSCREENED 0.35% no in-house ratios for this holding
KYMR Kymera Therapeutics, Inc. NON_COMPLIANT 0.34% AAOIFI0.7% Usmani4.3% Dow Jones Islamic1.4% S&P Shariah1.8% MSCI Islamic4.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0%
CYTK Cytokinetics, Inc. NON_COMPLIANT 0.34% AAOIFI7.3% Usmani29.6% Dow Jones Islamic7.7% S&P Shariah8.0% MSCI Islamic29.6% MSCI Islamic M-Series8.0% FTSE Shariah22.9%
PTGX Protagonist Therapeutics, Inc. NON_COMPLIANT 0.34% AAOIFI0.1% Usmani0.8% Dow Jones Islamic0.2% S&P Shariah0.2% MSCI Islamic0.8% MSCI Islamic M-Series0.2% FTSE Shariah0.0%
Crinetics Pharmaceuticals, Inc. UNSCREENED 0.32% no in-house ratios for this holding
Vaxcyte, Inc. UNSCREENED 0.31% no in-house ratios for this holding
TWST Twist Bioscience Corp. COMPLIANT 0.31% AAOIFI1.1% Usmani13.9% Dow Jones Islamic3.2% S&P Shariah3.5% MSCI Islamic13.9% MSCI Islamic M-Series3.5% FTSE Shariah0.0%
Immunovant, Inc. UNSCREENED 0.30% no in-house ratios for this holding
Apogee Therapeutics, Inc. UNSCREENED 0.29% no in-house ratios for this holding
IBRX ImmunityBio, Inc. COMPLIANT 0.29% AAOIFIpass Usmanifail Dow Jones Islamic— S&P Shariah— MSCI Islamicfail MSCI Islamic M-Series— FTSE Shariahfail
ALKS Alkermes plc COMPLIANT 0.28% AAOIFI19.9% Usmani35.4% Dow Jones Islamic27.5% S&P Shariah29.8% MSCI Islamic35.4% MSCI Islamic M-Series29.8% FTSE Shariah33.8%
Spyre Therapeutics, Inc. UNSCREENED 0.27% no in-house ratios for this holding
TXG 10X Genomics, Inc. COMPLIANT 0.26% AAOIFI0.9% Usmani7.1% Dow Jones Islamic2.3% S&P Shariah2.2% MSCI Islamic7.1% MSCI Islamic M-Series2.2% FTSE Shariah0.0%
RYTM Rhythm Pharmaceuticals, Inc. NON_COMPLIANT 0.26% AAOIFI1.3% Usmani24.0% Dow Jones Islamic1.9% S&P Shariah2.3% MSCI Islamic24.0% MSCI Islamic M-Series2.3% FTSE Shariah23.2%
CAI Caris Life Sciences, Inc. COMPLIANT 0.25% AAOIFI7.7% Usmani36.9% Dow Jones Islamic— S&P Shariah— MSCI Islamic36.9% MSCI Islamic M-Series— FTSE Shariah31.3%
Scholar Rock Holding Corp. UNSCREENED 0.24% no in-house ratios for this holding
CG oncology, Inc. UNSCREENED 0.23% no in-house ratios for this holding
Abivax SA UNSCREENED 0.23% no in-house ratios for this holding
TVTX Travere Therapeutics, Inc. COMPLIANT 0.22% AAOIFI10.0% Usmani77.2% Dow Jones Islamic24.4% S&P Shariah32.6% MSCI Islamic77.2% MSCI Islamic M-Series32.6% FTSE Shariah75.4%
Cogent Biosciences, Inc. UNSCREENED 0.21% no in-house ratios for this holding
MIRM Mirum Pharmaceuticals, Inc. COMPLIANT 0.21% AAOIFI12.4% Usmani72.4% Dow Jones Islamic17.9% S&P Shariah22.7% MSCI Islamic72.4% MSCI Islamic M-Series22.7% FTSE Shariah71.2%
Xenon Pharmaceuticals, Inc. UNSCREENED 0.21% no in-house ratios for this holding
PTCT PTC Therapeutics, Inc. NON_COMPLIANT 0.20% AAOIFI13.7% Usmani21.6% Dow Jones Islamic15.9% S&P Shariah18.7% MSCI Islamic21.5% MSCI Islamic M-Series18.7% FTSE Shariah18.4%
LGND Ligand Pharmaceuticals, Inc. COMPLIANT 0.20% AAOIFI19.7% Usmani51.8% Dow Jones Islamic34.1% S&P Shariah42.6% MSCI Islamic51.8% MSCI Islamic M-Series42.6% FTSE Shariah51.5%
Oruka Therapeutics, Inc. UNSCREENED 0.20% no in-house ratios for this holding
AMRX Amneal Pharmaceuticals, Inc. NON_COMPLIANT 0.20% AAOIFI39.5% Usmani57.1% Dow Jones Islamic77.5% S&P Shariah96.5% MSCI Islamic55.8% MSCI Islamic M-Series96.5% FTSE Shariah55.8%
Erasca, Inc. UNSCREENED 0.20% no in-house ratios for this holding
CRSP CRISPR Therapeutics AG NON_COMPLIANT 0.19% AAOIFI19.9% Usmani30.5% Dow Jones Islamic16.6% S&P Shariah16.4% MSCI Islamic30.5% MSCI Islamic M-Series16.4% FTSE Shariah23.0%
ACAD ACADIA Pharmaceuticals, Inc. COMPLIANT 0.17% AAOIFI2.3% Usmani4.0% Dow Jones Islamic1.9% S&P Shariah2.0% MSCI Islamic4.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
Edgewise Therapeutics, Inc. UNSCREENED 0.16% no in-house ratios for this holding
Definium Therapeutics, Inc. UNSCREENED 0.15% no in-house ratios for this holding
Indivior Pharmaceuticals, Inc. UNSCREENED 0.15% no in-house ratios for this holding
DYN Dyne Therapeutics, Inc. NON_COMPLIANT 0.15% AAOIFI7.0% Usmani17.7% Dow Jones Islamic9.1% S&P Shariah9.1% MSCI Islamic17.7% MSCI Islamic M-Series9.1% FTSE Shariah16.2%
ADPT Adaptive Biotechnologies Corp. COMPLIANT 0.14% AAOIFI1.6% Usmani10.8% Dow Jones Islamic3.2% S&P Shariah4.3% MSCI Islamic10.8% MSCI Islamic M-Series4.3% FTSE Shariah0.0%
Relay Therapeutics, Inc. UNSCREENED 0.14% no in-house ratios for this holding
Denali Therapeutics, Inc. UNSCREENED 0.13% no in-house ratios for this holding
Amylyx Pharmaceuticals, Inc. UNSCREENED 0.13% no in-house ratios for this holding
IOVA Iovance Biotherapeutics, Inc. COMPLIANT 0.13% AAOIFI1.3% Usmani4.6% Dow Jones Islamic2.5% S&P Shariah2.1% MSCI Islamic4.6% MSCI Islamic M-Series2.1% FTSE Shariah0.0%
KNSA Kiniksa Pharmaceuticals International plc COMPLIANT 0.13% AAOIFI0.1% Usmani0.8% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.8% MSCI Islamic M-Series0.3% FTSE Shariah0.0%
GPCR Structure Therapeutics, Inc. NON_COMPLIANT 0.13% AAOIFI0.5% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.5% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
Enliven Therapeutics, Inc. UNSCREENED 0.12% no in-house ratios for this holding
IDYA Ideaya Biosciences, Inc. NON_COMPLIANT 0.12% AAOIFI1.0% Usmani2.4% Dow Jones Islamic1.2% S&P Shariah1.1% MSCI Islamic2.4% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
ABCL AbCellera Biologics, Inc. NON_COMPLIANT 0.12% AAOIFI3.7% Usmani8.9% Dow Jones Islamic8.8% S&P Shariah9.6% MSCI Islamic8.9% MSCI Islamic M-Series9.6% FTSE Shariah0.0%
VCYT Veracyte, Inc. COMPLIANT 0.12% AAOIFI1.1% Usmani2.7% Dow Jones Islamic1.4% S&P Shariah1.6% MSCI Islamic2.7% MSCI Islamic M-Series1.6% FTSE Shariah0.0%
GRAL GRAIL, Inc. NON_COMPLIANT 0.12% AAOIFI1.8% Usmani3.1% Dow Jones Islamic3.5% S&P Shariah4.1% MSCI Islamic3.1% MSCI Islamic M-Series4.1% FTSE Shariah0.0%
TNGX Tango Therapeutics, Inc. NON_COMPLIANT 0.12% AAOIFI0.7% Usmani3.0% Dow Jones Islamic1.8% S&P Shariah2.1% MSCI Islamic3.0% MSCI Islamic M-Series2.1% FTSE Shariah0.0%
TARS Tarsus Pharmaceuticals, Inc. COMPLIANT 0.11% AAOIFI2.3% Usmani14.5% Dow Jones Islamic3.8% S&P Shariah4.7% MSCI Islamic14.5% MSCI Islamic M-Series4.7% FTSE Shariah11.9%
uniQure NV UNSCREENED 0.11% no in-house ratios for this holding
BEAM Beam Therapeutics, Inc. NON_COMPLIANT 0.11% AAOIFI10.7% Usmani19.2% Dow Jones Islamic9.9% S&P Shariah10.3% MSCI Islamic19.2% MSCI Islamic M-Series10.3% FTSE Shariah7.9%
Disc Medicine, Inc. UNSCREENED 0.11% no in-house ratios for this holding
ARQT Arcutis Biotherapeutics, Inc. COMPLIANT 0.11% AAOIFI3.2% Usmani21.9% Dow Jones Islamic4.5% S&P Shariah5.8% MSCI Islamic21.9% MSCI Islamic M-Series5.8% FTSE Shariah20.9%
Newamsterdam Pharma Co. NV UNSCREENED 0.10% no in-house ratios for this holding
MBX Biosciences, Inc. UNSCREENED 0.10% no in-house ratios for this holding
ATAI AtaiBeckley, Inc. NON_COMPLIANT 0.10% AAOIFI0.9% Usmani9.4% Dow Jones Islamic2.0% S&P Shariah2.5% MSCI Islamic9.4% MSCI Islamic M-Series2.5% FTSE Shariah8.7%
Alumis, Inc. UNSCREENED 0.09% no in-house ratios for this holding
NRIX Nurix Therapeutics, Inc. NON_COMPLIANT 0.09% AAOIFI4.2% Usmani5.5% Dow Jones Islamic4.4% S&P Shariah5.0% MSCI Islamic5.5% MSCI Islamic M-Series5.0% FTSE Shariah0.0%
Supernus Pharmaceuticals, Inc. UNSCREENED 0.09% no in-house ratios for this holding
GMAB.CO Genmab A/S COMPLIANT 0.09% AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
RARE Ultragenyx Pharmaceutical, Inc. NON_COMPLIANT 0.09% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
PGEN Precigen, Inc. NON_COMPLIANT 0.09% AAOIFI6.4% Usmani46.5% Dow Jones Islamic8.2% S&P Shariah10.8% MSCI Islamic46.5% MSCI Islamic M-Series10.8% FTSE Shariah44.4%
BCRX BioCryst Pharmaceuticals, Inc. NON_COMPLIANT 0.09% AAOIFI21.1% Usmani68.8% Dow Jones Islamic21.3% S&P Shariah23.8% MSCI Islamic68.5% MSCI Islamic M-Series23.8% FTSE Shariah66.9%
Vera Therapeutics, Inc. UNSCREENED 0.09% no in-house ratios for this holding
Pharvaris NV UNSCREENED 0.09% no in-house ratios for this holding
Trevi Therapeutics, Inc. UNSCREENED 0.08% no in-house ratios for this holding
Kodiak Sciences, Inc. UNSCREENED 0.08% no in-house ratios for this holding
Rapport Therapeutics, Inc. UNSCREENED 0.08% no in-house ratios for this holding
OCUL Ocular Therapeutix, Inc. NON_COMPLIANT 0.08% AAOIFI0.5% Usmani1.1% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.1% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
HRMY Harmony Biosciences Holdings, Inc. NON_COMPLIANT 0.08% AAOIFI8.0% Usmani10.5% Dow Jones Islamic7.9% S&P Shariah8.0% MSCI Islamic10.5% MSCI Islamic M-Series8.0% FTSE Shariah10.1%
SRPT Sarepta Therapeutics, Inc. NON_COMPLIANT 0.08% AAOIFI76.5% Usmani38.2% Dow Jones Islamic31.7% S&P Shariah18.8% MSCI Islamic38.2% MSCI Islamic M-Series18.8% FTSE Shariah32.1%
ADMA ADMA Biologics, Inc. COMPLIANT 0.08% AAOIFI6.7% Usmani27.7% Dow Jones Islamic5.7% S&P Shariah6.4% MSCI Islamic27.7% MSCI Islamic M-Series6.4% FTSE Shariah26.7%
ZYME Zymeworks, Inc. NON_COMPLIANT 0.08% AAOIFI19.4% Usmani33.3% Dow Jones Islamic27.5% S&P Shariah32.8% MSCI Islamic33.3% MSCI Islamic M-Series32.8% FTSE Shariah28.8%
Mineralys Therapeutics, Inc. UNSCREENED 0.07% no in-house ratios for this holding
URGN UroGen Pharma Ltd. NON_COMPLIANT 0.07% AAOIFI8.9% Usmani77.6% Dow Jones Islamic21.2% S&P Shariah25.0% MSCI Islamic75.9% MSCI Islamic M-Series25.0% FTSE Shariah74.7%
AUPH Aurinia Pharmaceuticals, Inc. COMPLIANT 0.07% AAOIFI0.2% Usmani7.1% Dow Jones Islamic0.2% S&P Shariah0.2% MSCI Islamic0.4% MSCI Islamic M-Series0.2% FTSE Shariah0.0%
NVCR Novocure Ltd. NON_COMPLIANT 0.07% AAOIFI4.6% Usmani7.3% Dow Jones Islamic3.3% S&P Shariah3.3% MSCI Islamic7.3% MSCI Islamic M-Series3.3% FTSE Shariah3.0%
ZBIO Zenas Biopharma, Inc. NON_COMPLIANT 0.07% AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2%
VCEL Vericel Corp. COMPLIANT 0.07% AAOIFI4.0% Usmani18.5% Dow Jones Islamic4.4% S&P Shariah4.4% MSCI Islamic18.4% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
Xencor, Inc. UNSCREENED 0.07% no in-house ratios for this holding
AGIO Agios Pharmaceuticals, Inc. NON_COMPLIANT 0.07% AAOIFI1.4% Usmani2.5% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic2.5% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
STOK Stoke Therapeutics, Inc. NON_COMPLIANT 0.07% AAOIFI0.1% Usmani0.5% Dow Jones Islamic0.1% S&P Shariah0.2% MSCI Islamic0.5% MSCI Islamic M-Series0.2% FTSE Shariah0.0%
Inhibrx Biosciences, Inc. UNSCREENED 0.07% no in-house ratios for this holding
GH Research plc UNSCREENED 0.07% no in-house ratios for this holding
VIR Vir Biotechnology, Inc. NON_COMPLIANT 0.07% AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0%
CMPS Compass Pathways plc NON_COMPLIANT 0.06% AAOIFI4.3% Usmani10.5% Dow Jones Islamic6.8% S&P Shariah7.7% MSCI Islamic10.5% MSCI Islamic M-Series7.7% FTSE Shariah9.8%
RXRX Recursion Pharmaceuticals, Inc. NON_COMPLIANT 0.06% AAOIFI4.4% Usmani6.1% Dow Jones Islamic7.3% S&P Shariah6.4% MSCI Islamic6.1% MSCI Islamic M-Series6.4% FTSE Shariah1.0%
NTLA Intellia Therapeutics, Inc. NON_COMPLIANT 0.06% AAOIFI16.8% Usmani25.5% Dow Jones Islamic16.2% S&P Shariah13.3% MSCI Islamic25.5% MSCI Islamic M-Series13.3% FTSE Shariah8.2%
PSNL Personalis, Inc. NON_COMPLIANT 0.06% AAOIFI2.3% Usmani12.4% Dow Jones Islamic4.6% S&P Shariah6.3% MSCI Islamic12.4% MSCI Islamic M-Series6.3% FTSE Shariah0.0%
LEGN Legend Biotech Corp. COMPLIANT 0.06% AAOIFI8.8% Usmani18.4% Dow Jones Islamic2.9% S&P Shariah2.3% MSCI Islamic18.4% MSCI Islamic M-Series2.3% FTSE Shariah18.4%
FTRE Fortrea Holdings, Inc. NON_COMPLIANT 0.06% AAOIFI58.6% Usmani40.8% Dow Jones Islamic91.2% S&P Shariah66.9% MSCI Islamic40.8% MSCI Islamic M-Series66.9% FTSE Shariah38.5%
SEPN Septerna, Inc. NON_COMPLIANT 0.06% AAOIFI1.2% Usmani3.6% Dow Jones Islamic2.1% S&P Shariahfail MSCI Islamic3.6% MSCI Islamic M-Seriesfail FTSE Shariah0.0%
SNDX Syndax Pharmaceuticals, Inc. NON_COMPLIANT 0.06% AAOIFI71.8% Usmani85.9% Dow Jones Islamic41.2% S&P Shariah39.2% MSCI Islamic85.9% MSCI Islamic M-Series39.2% FTSE Shariah85.8%
ANIP ANI Pharmaceuticals, Inc. NON_COMPLIANT 0.06% AAOIFI18.3% Usmani19.0% Dow Jones Islamic16.5% S&P Shariah17.6% MSCI Islamic19.0% MSCI Islamic M-Series17.6% FTSE Shariah19.0%
ANAB AnaptysBio, Inc. NON_COMPLIANT 0.06% AAOIFI0.9% Usmani4.1% Dow Jones Islamic1.1% S&P Shariah1.3% MSCI Islamic4.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
ETON Eton Pharmaceuticals, Inc. COMPLIANT 0.06% AAOIFI1.3% Usmani15.5% Dow Jones Islamic3.6% S&P Shariah5.0% MSCI Islamic15.5% MSCI Islamic M-Series5.0% FTSE Shariah14.7%
TSHA Taysha Gene Therapies, Inc. NON_COMPLIANT 0.06% AAOIFI3.9% Usmani12.5% Dow Jones Islamic5.1% S&P Shariah6.4% MSCI Islamic12.5% MSCI Islamic M-Series6.4% FTSE Shariah10.9%
ALVO Alvotech SA NON_COMPLIANT 0.06% AAOIFI61.2% Usmani87.4% Dow Jones Islamic56.2% S&P Shariah50.1% MSCI Islamic87.4% MSCI Islamic M-Series50.1% FTSE Shariah87.4%
IMCR Immunocore Holdings plc NON_COMPLIANT 0.06% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
NVAX Novavax, Inc. NON_COMPLIANT 0.05% AAOIFI22.2% Usmani33.3% Dow Jones Islamic21.5% S&P Shariah21.8% MSCI Islamic32.9% MSCI Islamic M-Series21.8% FTSE Shariah32.9%
INVA Innoviva, Inc. NON_COMPLIANT 0.05% AAOIFI20.5% Usmani17.5% Dow Jones Islamic19.4% S&P Shariah21.1% MSCI Islamic17.5% MSCI Islamic M-Series21.1% FTSE Shariah16.8%
BCAX Bicara Therapeutics, Inc. NON_COMPLIANT 0.05% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.2% MSCI Islamic M-Series— FTSE Shariah0.0%
TYRA Tyra Biosciences, Inc. COMPLIANT 0.05% AAOIFI0.4% Usmani0.8% Dow Jones Islamic0.5% S&P Shariah0.5% MSCI Islamic0.8% MSCI Islamic M-Series0.5% FTSE Shariah0.0%
MAZE Maze Therapeutics, Inc. COMPLIANT 0.05% AAOIFI3.3% Usmani11.7% Dow Jones Islamic4.7% S&P Shariahfail MSCI Islamic11.7% MSCI Islamic M-Seriesfail FTSE Shariah7.6%
First Tracks Biotherapeutics, Inc. UNSCREENED 0.05% no in-house ratios for this holding
XERS Xeris Biopharma Holdings, Inc. COMPLIANT 0.05% AAOIFI19.9% Usmani70.3% Dow Jones Islamic30.4% S&P Shariah39.2% MSCI Islamic70.3% MSCI Islamic M-Series39.2% FTSE Shariah61.3%
ABSI Absci Corp. COMPLIANT 0.05% AAOIFIpass Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
AVBP ArriVent Biopharma, Inc. NON_COMPLIANT 0.05% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
HROW Harrow, Inc. COMPLIANT 0.05% AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
Omeros Corp. UNSCREENED 0.05% no in-house ratios for this holding
CGEM Cullinan Therapeutics, Inc. NON_COMPLIANT 0.05% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
ORIC ORIC Pharmaceuticals, Inc. COMPLIANT 0.05% AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0%
MGTX MeiraGTx Holdings plc COMPLIANT 0.05% AAOIFI1.4% Usmani2.9% Dow Jones Islamic1.6% S&P Shariah2.0% MSCI Islamic2.9% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
Replimune Group, Inc. UNSCREENED 0.04% no in-house ratios for this holding
MNKD MannKind Corp. NON_COMPLIANT 0.04% AAOIFI25.3% Usmani45.8% Dow Jones Islamic23.8% S&P Shariah24.2% MSCI Islamic45.8% MSCI Islamic M-Series24.2% FTSE Shariah44.2%
VOR Vor BioPharma, Inc. NON_COMPLIANT 0.04% AAOIFI0.3% Usmani0.6% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic0.6% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
CRVS Corvus Pharmaceuticals, Inc. COMPLIANT 0.04% AAOIFI0.1% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
GLUE Monte Rosa Therapeutics, Inc. NON_COMPLIANT 0.04% AAOIFI4.6% Usmani5.2% Dow Jones Islamic4.2% S&P Shariah5.4% MSCI Islamic5.2% MSCI Islamic M-Series5.4% FTSE Shariah0.0%
MRVI Maravai LifeSciences Holdings, Inc. NON_COMPLIANT 0.04% AAOIFI10.4% Usmani37.6% Dow Jones Islamic18.2% S&P Shariah14.2% MSCI Islamic32.8% MSCI Islamic M-Series14.2% FTSE Shariah24.5%
KURA Kura Oncology, Inc. NON_COMPLIANT 0.04% AAOIFI3.8% Usmani4.6% Dow Jones Islamic3.4% S&P Shariah2.6% MSCI Islamic4.6% MSCI Islamic M-Series2.6% FTSE Shariah1.7%
JANX Janux Therapeutics, Inc. NON_COMPLIANT 0.04% AAOIFI3.1% Usmani2.1% Dow Jones Islamic1.5% S&P Shariah1.3% MSCI Islamic2.1% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
SVRA Savara, Inc. NON_COMPLIANT 0.04% AAOIFI3.1% Usmani19.4% Dow Jones Islamic3.7% S&P Shariah4.0% MSCI Islamic19.4% MSCI Islamic M-Series4.0% FTSE Shariah19.4%
Sana Biotechnology, Inc. UNSCREENED 0.04% no in-house ratios for this holding
PCRX Pacira BioSciences, Inc. COMPLIANT 0.04% AAOIFI23.3% Usmani28.3% Dow Jones Islamic32.3% S&P Shariah31.3% MSCI Islamic28.3% MSCI Islamic M-Series31.3% FTSE Shariah24.4%
CSTL Castle Biosciences, Inc. COMPLIANT 0.04% AAOIFI3.6% Usmani6.3% Dow Jones Islamic4.6% S&P Shariah4.9% MSCI Islamic6.3% MSCI Islamic M-Series4.9% FTSE Shariah1.7%
ABUS Arbutus Biopharma Corp. NON_COMPLIANT 0.04% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
AMPH Amphastar Pharmaceuticals, Inc. NON_COMPLIANT 0.04% AAOIFI55.2% Usmani40.4% Dow Jones Islamic57.2% S&P Shariah43.9% MSCI Islamic40.4% MSCI Islamic M-Series43.9% FTSE Shariah35.8%
CADL Candel Therapeutics, Inc. NON_COMPLIANT 0.03% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
GERN Geron Corp. NON_COMPLIANT 0.03% AAOIFI20.0% Usmani23.0% Dow Jones Islamic11.6% S&P Shariah8.9% MSCI Islamic23.0% MSCI Islamic M-Series8.9% FTSE Shariah22.8%
WVE Wave Life Sciences, Inc. NON_COMPLIANT 0.03% AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0%
SLDB Solid Biosciences, Inc. NON_COMPLIANT 0.03% AAOIFI2.8% Usmani5.0% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic5.0% MSCI Islamic M-Series4.6% FTSE Shariah0.0%
DSGN Design Therapeutics, Inc. NON_COMPLIANT 0.03% AAOIFI0.4% Usmani1.2% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.2% MSCI Islamic M-Series0.6% FTSE Shariah0.0%
GRF.MC Grifols SA NON_COMPLIANT 0.03% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
ARDX Ardelyx, Inc. NON_COMPLIANT 0.03% AAOIFI33.0% Usmani43.6% Dow Jones Islamic20.3% S&P Shariah18.8% MSCI Islamic43.6% MSCI Islamic M-Series18.8% FTSE Shariah43.0%
OLMA Olema Pharmaceuticals, Inc. NON_COMPLIANT 0.03% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
Theravance Biopharma, Inc. UNSCREENED 0.03% no in-house ratios for this holding
MESO Mesoblast Ltd. COMPLIANT 0.03% AAOIFI4.6% Usmani16.2% Dow Jones Islamic0.7% S&P Shariah0.9% MSCI Islamic16.2% MSCI Islamic M-Series0.9% FTSE Shariah16.2%
RIGL Rigel Pharmaceuticals, Inc. COMPLIANT 0.03% AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass
ACRS Aclaris Therapeutics, Inc. NON_COMPLIANT 0.03% AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.6% MSCI Islamic0.8% MSCI Islamic M-Series0.6% FTSE Shariah0.0%
9688.HK Zai Lab Ltd. NON_COMPLIANT 0.03% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
ANNX Annexon, Inc. COMPLIANT 0.03% AAOIFI9.8% Usmani29.2% Dow Jones Islamic46.7% S&P Shariah42.5% MSCI Islamic29.2% MSCI Islamic M-Series42.5% FTSE Shariah19.7%
COLL Collegium Pharmaceutical, Inc. NON_COMPLIANT 0.03% AAOIFI30.8% Usmani11.7% Dow Jones Islamic22.9% S&P Shariah22.6% MSCI Islamic11.7% MSCI Islamic M-Series22.6% FTSE Shariah11.4%
PAHC Phibro Animal Health Corp. NON_COMPLIANT 0.03% AAOIFI46.9% Usmani43.9% Dow Jones Islamic48.5% S&P Shariah59.2% MSCI Islamic43.9% MSCI Islamic M-Series59.2% FTSE Shariah40.3%
PHAT Phathom Pharmaceuticals, Inc. NON_COMPLIANT 0.03% AAOIFI37.6% Usmani48.7% Dow Jones Islamic23.5% S&P Shariah24.1% MSCI Islamic48.7% MSCI Islamic M-Series24.1% FTSE Shariah48.0%
Aura Biosciences, Inc. UNSCREENED 0.03% no in-house ratios for this holding
FDMT 4D Molecular Therapeutics, Inc. NON_COMPLIANT 0.03% AAOIFI6.2% Usmani9.0% Dow Jones Islamic9.4% S&P Shariah6.5% MSCI Islamic9.0% MSCI Islamic M-Series6.5% FTSE Shariah4.6%
CTMX CytomX Therapeutics, Inc. NON_COMPLIANT 0.03% AAOIFI1.0% Usmani1.2% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.2% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
IRWD Ironwood Pharmaceuticals, Inc. NON_COMPLIANT 0.02% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
Zevra Therapeutics, Inc. UNSCREENED 0.02% no in-house ratios for this holding
ALLO Allogene Therapeutics, Inc. NON_COMPLIANT 0.02% AAOIFI26.5% Usmani15.0% Dow Jones Islamic17.8% S&P Shariah16.2% MSCI Islamic15.0% MSCI Islamic M-Series16.2% FTSE Shariah0.0%
PRME Prime Medicine, Inc. NON_COMPLIANT 0.02% AAOIFI15.8% Usmani51.6% Dow Jones Islamic20.7% S&P Shariah19.0% MSCI Islamic51.6% MSCI Islamic M-Series19.0% FTSE Shariah0.0%
CRMD CorMedix, Inc. NON_COMPLIANT 0.02% AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
AQST Aquestive Therapeutics, Inc. COMPLIANT 0.02% AAOIFI12.8% Usmani52.8% Dow Jones Islamic13.5% S&P Shariah15.5% MSCI Islamic52.8% MSCI Islamic M-Series15.5% FTSE Shariah46.1%
SLN Silence Therapeutics plc NON_COMPLIANT 0.02% AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.1% MSCI Islamic M-Series0.0% FTSE Shariah0.0%
OABI OmniAb, Inc. NON_COMPLIANT 0.02% AAOIFI2.5% Usmani6.2% Dow Jones Islamic5.3% S&P Shariah4.4% MSCI Islamic6.2% MSCI Islamic M-Series4.4% FTSE Shariah0.0%
SGMT Sagimet Biosciences, Inc. NON_COMPLIANT 0.02% AAOIFI0.3% Usmani0.7% Dow Jones Islamic1.0% S&P Shariah1.1% MSCI Islamic0.7% MSCI Islamic M-Series1.1% FTSE Shariah0.0%
ALT Altimmune, Inc. NON_COMPLIANT 0.02% AAOIFI11.3% Usmani7.3% Dow Jones Islamic7.7% S&P Shariah7.6% MSCI Islamic7.3% MSCI Islamic M-Series7.6% FTSE Shariah7.1%
EOLS Evolus, Inc. NON_COMPLIANT 0.02% AAOIFI37.7% Usmani58.3% Dow Jones Islamic31.2% S&P Shariah26.9% MSCI Islamic58.3% MSCI Islamic M-Series26.9% FTSE Shariah55.3%
SPRY ARS Pharmaceuticals, Inc. NON_COMPLIANT 0.02% AAOIFI33.2% Usmani48.4% Dow Jones Islamic12.0% S&P Shariah12.4% MSCI Islamic48.4% MSCI Islamic M-Series12.4% FTSE Shariah48.4%
ARVN Arvinas, Inc. NON_COMPLIANT 0.02% AAOIFI1.7% Usmani1.3% Dow Jones Islamic1.0% S&P Shariah0.6% MSCI Islamic1.3% MSCI Islamic M-Series0.6% FTSE Shariah0.1%
NGNE Neurogene, Inc. NON_COMPLIANT 0.02% AAOIFI1.6% Usmani2.0% Dow Jones Islamic2.0% S&P Shariah2.0% MSCI Islamic2.0% MSCI Islamic M-Series2.0% FTSE Shariah0.0%
TECX Tectonic Therapeutic, Inc. NON_COMPLIANT 0.02% AAOIFI0.7% Usmani1.9% Dow Jones Islamic0.9% S&P Shariah1.2% MSCI Islamic1.8% MSCI Islamic M-Series1.2% FTSE Shariah0.0%
CTNM Contineum Therapeutics, Inc. NON_COMPLIANT 0.02% AAOIFI1.7% Usmani2.4% Dow Jones Islamic2.5% S&P Shariah2.3% MSCI Islamic2.4% MSCI Islamic M-Series2.3% FTSE Shariah0.0%
KYTX Kyverna Therapeutics, Inc. NON_COMPLIANT 0.02% AAOIFI10.9% Usmani17.1% Dow Jones Islamic10.6% S&P Shariah8.5% MSCI Islamic17.1% MSCI Islamic M-Series8.5% FTSE Shariah13.2%
CABA Cabaletta Bio, Inc. NON_COMPLIANT 0.02% AAOIFI2.0% Usmani6.9% Dow Jones Islamic1.9% S&P Shariah1.3% MSCI Islamic1.4% MSCI Islamic M-Series1.3% FTSE Shariah0.0%
RGNX REGENXBIO, Inc. NON_COMPLIANT 0.02% AAOIFI13.9% Usmani14.3% Dow Jones Islamic13.6% S&P Shariah11.9% MSCI Islamic14.3% MSCI Islamic M-Series11.9% FTSE Shariah0.0%
PRTA Prothena Corp. plc NON_COMPLIANT 0.02% AAOIFI1.5% Usmani2.2% Dow Jones Islamic1.2% S&P Shariah0.8% MSCI Islamic2.2% MSCI Islamic M-Series0.8% FTSE Shariah0.0%
Kamada Ltd. UNSCREENED 0.02% no in-house ratios for this holding
AUTL Autolus Therapeutics plc NON_COMPLIANT 0.02% AAOIFI50.1% Usmani29.8% Dow Jones Islamic32.6% S&P Shariah23.0% MSCI Islamic29.8% MSCI Islamic M-Series23.0% FTSE Shariah14.3%
EDIT Editas Medicine, Inc. NON_COMPLIANT 0.02% AAOIFI24.5% Usmani32.3% Dow Jones Islamic29.0% S&P Shariah21.2% MSCI Islamic32.3% MSCI Islamic M-Series21.2% FTSE Shariah25.9%
PBYI Puma Biotechnology, Inc. COMPLIANT 0.02% AAOIFI1.3% Usmani2.4% Dow Jones Islamic1.7% S&P Shariah1.9% MSCI Islamic2.4% MSCI Islamic M-Series1.9% FTSE Shariah0.0%
LKFT.AS Lakefront Biotherapeutics NV NON_COMPLIANT 0.02% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
AVIR Atea Pharmaceuticals, Inc. NON_COMPLIANT 0.02% AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
BIOA BioAge Labs, Inc. NON_COMPLIANT 0.01% AAOIFI1.1% Usmani0.7% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic0.7% MSCI Islamic M-Series— FTSE Shariah0.0%
PACB Pacific Biosciences of California, Inc. NON_COMPLIANT 0.01% AAOIFI123.9% Usmani97.8% Dow Jones Islamic147.8% S&P Shariah107.9% MSCI Islamic97.8% MSCI Islamic M-Series107.9% FTSE Shariah89.2%
ARCT Arcturus Therapeutics Holdings, Inc. NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
CCCC C4 Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
RCKT Rocket Pharmaceuticals, Inc. NON_COMPLIANT 0.01% AAOIFI14.3% Usmani13.1% Dow Jones Islamic6.6% S&P Shariah3.2% MSCI Islamic8.1% MSCI Islamic M-Series3.2% FTSE Shariah7.3%
LRMR Larimar Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI1.6% Usmani3.0% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic3.0% MSCI Islamic M-Series1.4% FTSE Shariah0.0%
Enanta Pharmaceuticals, Inc. UNSCREENED 0.01% no in-house ratios for this holding
TKNO Alpha Teknova, Inc. COMPLIANT 0.01% AAOIFI7.3% Usmani28.6% Dow Jones Islamic9.7% S&P Shariah12.3% MSCI Islamic28.6% MSCI Islamic M-Series12.3% FTSE Shariah13.8%
EYPT EyePoint, Inc. NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail
Lexeo Therapeutics, Inc. UNSCREENED 0.01% no in-house ratios for this holding
UPB Upstream Bio, Inc. NON_COMPLIANT 0.01% AAOIFI0.4% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0%
FHTX Foghorn Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI40.9% Usmani23.0% Dow Jones Islamic16.1% S&P Shariah15.7% MSCI Islamic23.0% MSCI Islamic M-Series15.7% FTSE Shariah0.0%
LYEL Lyell Immunopharma, Inc. NON_COMPLIANT 0.01% AAOIFI13.2% Usmani16.2% Dow Jones Islamic14.3% S&P Shariah12.1% MSCI Islamic16.2% MSCI Islamic M-Series12.1% FTSE Shariah0.0%
VNDA Vanda Pharmaceuticals, Inc. NON_COMPLIANT 0.01% AAOIFI6.5% Usmani5.5% Dow Jones Islamic4.9% S&P Shariah5.1% MSCI Islamic3.8% MSCI Islamic M-Series5.1% FTSE Shariah0.0%
Immuneering Corp. UNSCREENED 0.01% no in-house ratios for this holding
OBIO Orchestra BioMed Holdings, Inc. COMPLIANT 0.01% AAOIFI4.1% Usmani20.7% Dow Jones Islamic10.3% S&P Shariah10.1% MSCI Islamic20.7% MSCI Islamic M-Series10.1% FTSE Shariah19.6%
Invivyd, Inc. UNSCREENED 0.01% no in-house ratios for this holding
TRDA Entrada Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI17.5% Usmani16.2% Dow Jones Islamic12.3% S&P Shariah11.3% MSCI Islamic16.2% MSCI Islamic M-Series11.3% FTSE Shariah0.0%
SION Sionna Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI5.6% Usmani2.9% Dow Jones Islamic0.7% S&P Shariah— MSCI Islamic2.9% MSCI Islamic M-Series— FTSE Shariah0.0%
ACIU AC Immune SA NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
Anavex Life Sciences Corp. UNSCREENED 0.01% no in-house ratios for this holding
FULC Fulcrum Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI2.4% Usmani2.2% Dow Jones Islamic1.9% S&P Shariah1.8% MSCI Islamic2.2% MSCI Islamic M-Series1.8% FTSE Shariah0.0%
Neumora Therapeutics, Inc. UNSCREENED 0.01% no in-house ratios for this holding
SIGA SIGA Technologies, Inc. NON_COMPLIANT 0.01% AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.2% MSCI Islamic M-Series0.1% FTSE Shariah0.0%
KROS Keros Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI6.8% Usmani4.9% Dow Jones Islamic2.9% S&P Shariah1.6% MSCI Islamic4.9% MSCI Islamic M-Series1.6% FTSE Shariah0.0%
VYGR Voyager Therapeutics, Inc. NON_COMPLIANT 0.01% AAOIFI17.2% Usmani16.5% Dow Jones Islamic13.5% S&P Shariah11.1% MSCI Islamic16.5% MSCI Islamic M-Series11.1% FTSE Shariah0.0%
CHRS Coherus Oncology, Inc. NON_COMPLIANT 0.01% AAOIFI70.3% Usmani32.1% Dow Jones Islamic32.0% S&P Shariah29.8% MSCI Islamic32.1% MSCI Islamic M-Series29.8% FTSE Shariah30.7%
PEPG PepGen, Inc. NON_COMPLIANT 0.01% AAOIFI5.8% Usmani12.2% Dow Jones Islamic9.5% S&P Shariah7.0% MSCI Islamic12.2% MSCI Islamic M-Series7.0% FTSE Shariah0.0%
PYXS Pyxis Oncology, Inc. NON_COMPLIANT 0.01% AAOIFI10.1% Usmani22.7% Dow Jones Islamic13.2% S&P Shariah11.3% MSCI Islamic22.7% MSCI Islamic M-Series11.3% FTSE Shariah0.0%
NBP NovaBridge Biosciences NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariah— MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail
50BA.SG Bicycle Therapeutics plc NON_COMPLIANT 0.01% AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail

The published standards disagree about this fund by 23 points of portfolio weight — 26.7% of it passes AAOIFI, 3.6% passes MSCI Islamic. Which number is yours depends on which standard you follow.

These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.

ratios pass on 26.7% ratios fail on 12.8% 56.5% not rated under AAOIFI

196 of 264 listed holdings carry our own per-methodology verdicts (46% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 171 (42% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.

Non-compliant holdingWeight
MRNA Moderna, Inc. 1.96%
RVMDW Revolution Medicines, Inc. 1.54%
RPRX Royalty Pharma plc 0.96%
UTHR United Therapeutics Corp. 0.76%
VTRS Viatris, Inc. 0.68%
JAZZ Jazz Pharmaceuticals plc 0.55%
BMRN BioMarin Pharmaceutical, Inc. 0.44%
22UA.DE BioNTech SE 0.42%
KRYS Krystal Biotech, Inc. 0.37%
IONS Ionis Pharmaceuticals, Inc. 0.35%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure0 of 4 timeframes bullish · 100.0% aligned
VWAPPrice below VWAP ($114.31)
VolumeRelative volume 2.1× the 20-day average
Momentum10-day rate of change -13.4%

ProShares Ultra Nasdaq Biotechnology (BIB) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.

Market & analysts
Momentum (10d)
-13.4%
rate of change
SMC grade
C · 55
100.0% aligned
C · 55
SMC grade — 100.0% timeframe alignment
-13.4%
Rate of change (10d)

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for BIB — this runs off the critical path so the page paints first. It will appear here on its own.

Tracked investors holding BIB
InvestorFirmPositionWeightAs of
Ken Griffin Citadel Advisors $1M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

126.13113.0499.9486.8573.762025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
105.73
S2
106.86
S1
108.36
PIVOT
109.49
R1
110.99
R2
112.12
R3
113.62

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
104.93 – 123.59
±8.16% from 114.26, made 2026-09-24 · resolves 2026-10-01
STRONG BUY
from 19 indicators
77.1% of our last 20463 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 50.1% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
2 buy · 0 neutral · 10 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)42.40NEUTRAL
Stochastic %K (14)2.18BUY
CCI (20)-128.54BUY
Williams %R (14)-97.82BUY
MACD (12,26,9)-1.40SELL
ROC (10)-13.37SELL
Momentum (10)-16.73SELL
EMA (10)114.64SELL
SMA (10)116.29SELL
EMA (20)115.26SELL
SMA (20)116.65SELL
EMA (30)114.84SELL
SMA (30)114.00SELL
EMA (50)113.51SELL
SMA (50)113.16SELL
EMA (100)108.80SELL
SMA (100)110.56SELL
EMA (200)98.70BUY
SMA (200)96.95BUY

About ProShares Ultra Nasdaq Biotechnology

The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.

Background via Yahoo Finance — informational, not part of the verdict.

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 43
🕐 1H BEARISH 24
⏱ 15-Min BEARISH 98
⏲ 5-Min BEARISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-13.4%
Rate of change (10d)
2.1×
Volume vs its 20-day average
-0.10
MACD (no fresh cross)
$110.12
Volume POC (today)
$109.65 – $110.14
Value area

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is a fund screened on its name?

No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.

What does unrated weight mean?

It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.

Does the issuer's board make it compliant?

It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.

How often is this re-screened?

When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.